Morphine use in acute cardiogenic pulmonary oedema: is MIMO trial enough to change practice? Letter regarding the article 'Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial'
- PMID: 36280385
- DOI: 10.1002/ejhf.2724
Morphine use in acute cardiogenic pulmonary oedema: is MIMO trial enough to change practice? Letter regarding the article 'Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial'
Comment in
-
Reply to 'Morphine use in acute cardiogenic pulmonary oedema: is MIMO trial enough to change practice?'.Eur J Heart Fail. 2022 Dec;24(12):2393-2394. doi: 10.1002/ejhf.2734. Epub 2022 Nov 17. Eur J Heart Fail. 2022. PMID: 36377097 No abstract available.
Comment on
-
Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial.Eur J Heart Fail. 2022 Oct;24(10):1953-1962. doi: 10.1002/ejhf.2602. Epub 2022 Jul 16. Eur J Heart Fail. 2022. PMID: 35780488 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
